Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Choice of Upstream Bioreactor Technologies for Industrial Scale Viral Manufacturing (White Paper USD3244)
Pall Corporation
Process Analytical Technology For Upstream Bioprocessing
Erica Fratz-Berilla and Cyrus Agarabi, FDA CDER
Changing Column Packing from an Art into a Science
Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release
By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer
Headline News
Intranasal foralumab reduces microglial activation in Phase IIa progressive MS trial
Teva discontinues Phase II emrusolmin trial in multiple system atrophy after futility analysis
FDA grants Priority Review to uniQure’s Huntington’s disease gene therapy
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Single Use Manufacturing within the Bristol-Myers Squibb Manufacturing Network – Preparing for Commercial Production
Presented by Lance Marquardt, Associate Director - Upstream Processing for Hopewell Clinical Manufacturing at Bristol-Myers Squibb and Sara Bell, Senior Marketing Manager for Merck’s single-use product portfolio
17th January 2019
Patient-Centric Drug Delivery Strategies For Oral Paediatric Products
Presented by Dr. Carsten Timpe Senior Principal Scientist at Hoffman La Roche AG and Dr. Paolo Gatti Research Fellow and Formulation Manager for Aptalis Pharmaceutical Technologies
22nd April 2015
DSF and FTIR as complementary methods for the identification and characterization of vaccine products
Presented by Marina Kirkitadze, Deputy Director, Head of Biophysics & Conformation Unit, Analytical R&D Biochemistry, Sanofi Pasteur and Rina Dukor, President, BioTools
18th September 2018
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Column Packing Protocol for Amsphere A3
Rationale Design of Valves for Flexible Processing
Best Practices for Achieving Virus Safety
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
